Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association
May 16, 2019 10:02 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 16, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
Aptose to Present at May Investor Conferences
May 13, 2019 08:15 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, May 13, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...
Aptose Reports Results for the First Quarter Ended March 31, 2019
May 07, 2019 16:01 ET
|
Aptose Biosciences, Inc.
─ Patient Dosed at Second Dose Level in APTO-253 Clinical Trial ─ ─ Patient Screening Initiated for CG-806 Clinical Trial ─ Conference Call and Webcast at 5pm EDT Today SAN DIEGO and TORONTO, May...
Aptose to Present at the Bloom Burton & Co. Healthcare Investor Conference 2019
April 24, 2019 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, April 24, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...
Aptose To Release First Quarter Ended March 31, 2019 Financial Results and Hold Conference Call on May 7, 2019
April 23, 2019 07:30 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, April 23, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO; TSX: APS), a clinical-stage biotechnology company developing first-in-class agents that target the...
Aptose to Present at the H.C. Wainwright Annual Global Life Sciences Conference
April 02, 2019 07:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, April 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
Aptose to Present New CG-806 and APTO-253 Data at the 2019 AACR Annual Meeting
February 28, 2019 07:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage company developing highly differentiated...
Aptose Biosciences to Present at Biotech Showcase™ 2019 Conference
January 02, 2019 07:05 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Jan. 02, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage company developing highly differentiated therapeutics that target the...
Aptose Presents Highlights From CG-806 KOL Event
December 12, 2018 10:00 ET
|
Aptose Biosciences, Inc.
SAN DIEGO and TORONTO, Dec. 12, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) released highlights from a Key Opinion Leader (KOL) breakfast featuring a presentation by...
OHSU and Aptose Present New CG-806 Preclinical Data at ASH 60th Annual Meeting
December 03, 2018 07:10 ET
|
Aptose Biosciences, Inc.
PORTLAND, Ore. and SAN DIEGO, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Oregon Health & Science University (OHSU) and Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) today announced the presentation of...